DOVILIA

EUIPO EUIPO 2010 Application withdrawn

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark DOVILIA was filed as Word mark on 12/21/2010 at the European Union Intellectual Property Office. The current status of the mark is "Application withdrawn".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 009615881
Application date December 21, 2010
Publication date March 29, 2011

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Bedford House, John Street WC1N 2BF London GB

goods and services

5 Pharmaceutical preparations, namely pharmaceutical preparations for the treatment of cancer/oncology; pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders, diabetes, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, reproductive system diseases and disorders, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; antipsychotics; antidepressants; anxiety spectrum disorders; atherosclerosis; Alzheimers; pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohns disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders; pharmaceutical preparations

ID: 11009615881